Eqvista Profiles Talus Bio CEO in its Founder Spotlight Interview Series

Alex Federation shares company momentum on the heels of Talus Bio’s $11.2M seed extension financing and early traction in the new year in Eqvista’s Founder Spotlight series. Don’t miss the full interview to discover the beginnings of our mission to drug the undruggable and how the Talus Bio team blends functional proteomics, automated biology, and AI to massively accelerate drug discovery for transcription factor therapeutics.